Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsuo Numata is active.

Publication


Featured researches published by Mitsuo Numata.


The Journal of Antibiotics | 1978

NEW CEPHALOSPORINS WITH 7-ACYL GROUPS DERIVED FROM β-KETOACIDS

Mitsuo Numata; Masayoshi Yamaoka; Isao Minamida; Masaaki Kuritani; Yoshio Imashiro

The synthesis and antimicrobial profile of a series of 7-(beta-ketoacylamino)cephalosporins (1) bearing an acetoxymethyl or a heterocyclichiomethyl group at the 3-position are described. Of this series, 3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-7-(3-oxobutyrylamino)ceph-3-em-4-carboxylic acid (11) showed moderate antibacterial activities in in vitro and in vivo tests.


Biochemical Pharmacology | 1968

The metabolism of the octamethylene-1,8-dithiol moiety of BIS(O-acetylthiamine)octamethylene-1,8-disulfide in rat and man☆

Kohei Nishikawa; Ziro Suzuoki; Mitsuo Numata

Abstract Metabolic fate and urinary metabolites of the octamethylene-1,8-dithiol moiety of bis ( O -acetylthiamine)-octamethylene-1,8-disulfide (BTOD) have been studied in rat and man. Following the i.v. administration of 35 S-labeled BTOD, the rat excreted about 75 per cent of the administered radioactivity in urine and 4 per cent in feces within 2 days. Upon the oral or i.p. administration, the rat excreted 44–50 per cent in urine and 35–45 per cent in feces. No significant radioactivity was found in the respiratory gas in either cases. Three metabolites were isolated by silicic acid chromatography from urine obtained after oral administration of the compound. The spectrometric data (infrared and nuclear magnetic resonance) demonstrated that their chemical structures were 1,8- bis (methylsulfinyl)octane, 1-methylsulfinyl-8-methylsulfonyloctane and 1,8- bis (methylsulfonyl)octane, respectively. The identity of these-metabolites was conclusively established by comparison studies with authentic compounds which were chemically synthesized. These three metabolites were also recognized in the human urine after oral administration of nonlabeled BTOD. The excretion pattern of the radioactivity following the oral administration of 35 S-labeled octamethylene-1,8-dithiol was very similar to that obtained with BTOD. Identical metabolites were characterized in urine after i.p. administration of the dithiol. The present studies show that the sulfur in the compounds is metabolized solely by the methylsulfonyl pathway and conversion to inorganic sulfate does not occur in any appreciable amount.


The Journal of Antibiotics | 1987

ORALLY ACTIVE 1-(CYCLOHEXYLOXYCARBONYLOXY)ALKYL ESTER PRODRUGS OF CEFOTIAM

Tatsuo Nishimura; Yoshinobu Yoshimura; Akio Miyake; Masayoshi Yamaoka; Kunio Takanohashi; Naoru Hamaguchi; Shin-Ichiro Hirai; Takatsuka Yashiki; Mitsuo Numata


The Journal of Antibiotics | 1978

A new cephalosporin. SCE-963: 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]-thio]methyl]ceph-3-em-4-carboxylic acid. Chemistry and structure-activity relationships.

Mitsuo Numata; Isao Minamida; Masayoshi Yamaoka; Mitsuru Shiraishi; Toshio Miyawaki; Hiroshi Akimoto; Kenzo Naito; Makoto Kida


Tetrahedron Letters | 1972

Brugierol and Isobrugierol, trans- and cis-1,2-dithiolane-1-oxide, from Brugiera conjugata

Atsushi Kato; Mitsuo Numata


Archive | 1977

7-[2-(2-Imino-4-thiazolin-4-yl)-2-(syn)-hydroxy-iminoacetamido]-cephalosporins

Mitsuo Numata; Isao Minamida; Susumu Tsushima


Archive | 1974

7-Alpha-(2-aminothiazole)-acetamido-cephalosporins

Mitsuo Numata; Isao Minamida; Masayoshi Yamaoka; Mitsuru Shiraishi; Toshio Miyawaki


Chemical & Pharmaceutical Bulletin | 1965

Synthesis of Nereistoxin and Related Compounds. II

Mitsuo Numata; Hikoichi Hagiwara


Archive | 1981

2-Oxoazetidine derivatives and production thereof

Mitsuo Numata; Masayoshi Yamaoka; Tatsuo Nishimura; Norichika Matsumoto


Archive | 1978

7[(2-Thiazolyl)-2-(oxoimino)acetamido]cephalosporin derivatives

Mitsuo Numata; Tatsuo Nishimura

Collaboration


Dive into the Mitsuo Numata's collaboration.

Top Co-Authors

Avatar

Isao Minamida

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masayoshi Yamaoka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Susumu Tsushima

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Toshio Miyawaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tatsuo Nishimura

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Norichika Matsumoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshinobu Yoshimura

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshio Imashiro

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hideki Uneme

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge